James Campbell
Chief Executive, Managing Director / Patrys
Most Notable Role
Dr James Campbell has extensive experience as a scientist and commercial executive within the medical sector.
He was chief financial officer and chief operating officer of Chemgenex which was acquired by Cephalon for $230million in 2011. At ChemGenex, his responsibilities ranged from intellectual property management to licensing and business development. Dr Campbell had also guided the creation of Invion Limited as an executive director, and assisted private biotechnology companies in New Zealand and the US with capital raising and partnering negotiations.
